Metraipolis › archive › dc_5c16ea86d538
Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival — Europe PMC PMID:42203742
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42203742
- DOI
- 10.1093/oncolo/oyag209
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T23:58:38.982Z
- SHA-256 of the archived text
02b2b8b1d066e7130a0a19f7bb71f83520629b9aa7eaa7639d2ef7a2e77693c0- Stable URL of this page
https://metraipolis.com/documento/dc_5c16ea86d538
How to cite
Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival — Europe PMC PMID:42203742 — Europe PMC (en), https://europepmc.org/article/MED/42203742 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5c16ea86d538 (Metraipolis archive dc_5c16ea86d538, sha256 02b2b8b1d066e7130a0a19f7bb71f83520629b9aa7eaa7639d2ef7a2e77693c0)
BibTeX
@misc{dc5c16ea86d538,
title = {Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival — Europe PMC PMID:42203742},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42203742},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5c16ea86d538; sha256 02b2b8b1d066e7130a0a19f7bb71f83520629b9aa7eaa7639d2ef7a2e77693c0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42203742. Agents can read the archived copy with the MCP tool read_document.